Shan Yuan, M.D.

800-826-4673
Shan Yuan, M.D.
Pathologist
Clinical Expertise
Transfusion Medicine
Languages
Mandarin
Appointments
Clinical Professor, Department Of Pathology
Medical Director, Blood Bank And Transfusion Services
Shan Yuan, M.D., has served as a physician in Transfusion Medicine at City of Hope.
 
A multiple honors student dating back to her college days, Dr. Yuan received her medical degree from Duke University in Durham, North Carolina and completed her fellowship training in transfusion medicine at Bloodworks Northwest, formerly known as Puget Sound Blood Center, in Seattle, Washington.
 
Dr. Yuan has served as City of Hope's assistant medical director of transfusion medicine since 2012, following a five-year term in similar capacity at UCLA's David Geffen School of Medicine. She is a sought-after lecturer and prolific publisher on all aspects of transfusion and stem cell transplants.
Location
Education & Experience
Board Certifications

  • American Board of Pathology, Blood Banking/Transfusion Medicine

  • American Board of Pathology, Clinical Pathology

  • Unrestricted Medical License, State of California

  • United States Medical Licensing Examination

Degrees

  • 1996-2000, Doctor of Medicine, Duke University School of Medicine, Durham, NC

  • 1992 –1996, Bachelor of Arts, Biology, Oberlin College, Oberlin, OH

Fellowship

  • 2004 –2005, Fellow, Transfusion Medicine, Puget Sound Blood Center and University of Washington Medical Center, Seattle, WA

Residency

  • 2000 –2004, Chief Resident, Laboratory Medicine (2003-2004), Resident, Anatomic Pathology and Laboratory Medicine, University of Washington Medical Center, Seattle, WA

Professional Experience

  • 2012 - present, Associate Clinical Professor, Department of Pathology, City of Hope, Duarte, CA

  • 2007 - 2012, Associate Medical Director of Transfusion Medicine, Assistant Professor, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

  • 2005 - 2007, Staff Physician, Transfusion Medicine, City of Hope, Duarte, CA

Awards & Memberships
Awards

  • 2010-2011, Faramarz Naeim Faculty Teaching Award for Clinical Pathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA

  • 2004, Paul E. Strandjord Young Investigator Award, 39th Annual Meeting of the Academy of Clinical Physicians and Scientists

  • 2003, Strandjord-Clayson Research Award, Department of Laboratory Medicine, University of Washington Medical Center

  • 2003, Paul E. Strandjord Young Investigator Award, 38th Annual Meeting of the Academy of Clinical Physicians and Scientists

Memberships

  • American Association of Blood Banks

  • California Blood Bank Society

  • American Society of Hematology

Publications
  • Yuan S, Otrock ZK. Platelet Transfusion: An Update on Indications and Guidelines. Clin Lab Med. 2021 Dec;41(4):621-634.
  • Zhuang L, Lauro D, Wang S, Yuan S. Addition of plerixafor in poorly mobilized allogeneic stem cell donors. J Clin Apher. 2022 Aug;37(4):388-394.
  • Yuan S, Yang DY, Nakamura R, Zhuang LF, Al Malki MM, Karanes C, Wang S. RBC and platelet transfusion requirements in the first 30 and 100 days after allogeneic hematopoietic cell transplantation and transfusion independence.  Transfusion 2020;60:2225-2242.
  • Zhuang L, Boriboonnangkul P, Wang S, Yuan S. Third time’s a charm? Mobilization of autologous peripheral blood stem cells in patients with two previous failed mobilizations with plerixafor.  Transfusion 2020;60:1253-1259
  • Yuan S,  Zhuang LF, Stinson S, Barton P, Noeller J, Garcia A, Wang S. Red cell clumping in  stem cell collection bag. Transfusion 
    2020;60:673-674.
  • Yuan S, Yang DY, Nakamura R, Zhuang LF, Al Malki M, Wang S. RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation. Transfusion 2019; 59:3371-3385.
  • Park G, Shayani S, Stiller T, Wang S, Yuan S. Dose-capping of plerixafor in patients weighing >100 kg at one vial led to successful mobilization outcomes and significant cost savings. Transfusion 2018; 58:323-329.
  • Salhotra A, Yuan S, Tsai NC, Sanchez JF, Aldoss I, Ali H, Paris T, Spielberger R, Cao TM, Nademanee A, Forman ST, Chen R. Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure Despite Plerixafor Rescue. Biology of Blood and Marrow Transplantation 2017; 23:1264-1268.
  • Yuan S, Wang S. How do we mobilize and collect autologous peripheral blood stem cells. Transfusion 2016; 57:13-23.
  • Finck RH, Ziman A, Hoffman M, Phan-Tang M, Yuan S. Motivating factors and potential deterrents to blood donation in high school aged blood donors. Accepted for publication by Journal of Blood Transfusion 2016;2016:8624230. doi: 10.1155/2016/8624230. Epub 2016 May 15. 
  • Yuan S, Palmer JM, Tsai N, Dagis A, Nademanee A, Wang S. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor Hematol Oncol. 2017:35:281-287.
  • Salhotra A, Yuan S, Tsai NC, Sanchez JF, Aldoss I, Ali H, Paris T, Spielberger R, Cao TM, Nademanee A, Forman ST, Chen R. Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure Despite Plerixafor Rescue. Biology of Blood and Marrow Transplantation 2017; 23:1264-1268.
  • Yuan S, Chang S, Uyeno K, Almquist G, Wang S. Blood donation mobile applications: Are donors ready? Transfusion. 2016; 56:614-621.
  • Yuan S, Palmer JM, Tsai N, Dagis A, Nademanee A, Wang S. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor Hematol Oncol. 2016 Feb 29;2016 DOI: 10.1002/hon.2286. [Epub ahead of print]
  • Finck RH, Ziman A, Hoffman M, Phan-Tang M, Yuan S. Motivating factors and potential deterrents to blood donation in high school aged blood donors. Accepted for publication by Journal of Blood Transfusion 2016;2016:8624230. DOI: 10.1155/2016/8624230. Epublished.
  • Yuan S, Wang S. How do we mobilize and collect autologous peripheral blood stem cells. Transfusion 2016; 57:13-23.
  • Yuan S, Nademanee A, Kaniewski M, Palmer J, Shayani S, Wang S. Efficacy of Just-in-Time Plerixafor Rescue for Hodgkin Lymphoma Patients with Poor Peripheral Blood Stem Cell Mobilization. Transfusion. 2014;54:2015-2021.